Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 70710-1700

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 70710-1700). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Eb320e98 85d0 421f 963d 825fb8e3c621 01)

Chemical structure of venlafaxine hydrochloride, showing its molecular arrangement including a methoxyphenyl group, a cyclohexanol moiety, and an N,N-dimethylethylamine side chain, with hydrochloride indicated.*

FDA Label Image

Image (Eb320e98 85d0 421f 963d 825fb8e3c621 02)

A dot plot chart showing the fold change and 90% confidence intervals for venlafaxine and its metabolite ODV across various special populations and pharmacokinetic parameters such as Cmax and AUC. Special populations include hepatic impairment of varying degrees, renal impairment, CYP2D6 polymorphism status, age over 60, and gender differences. The x-axis represents change relative to the reference value.*

FDA Label Image

Image (Eb320e98 85d0 421f 963d 825fb8e3c621 03)

A chart showing the fold change and 90% confidence intervals for the pharmacokinetic parameters Cmax and AUC of venlafaxine and its ODV metabolite when co-administered with various interacting drugs including ethanol, diazepam, cimetidine, ketoconazole (in CYP2D6 EM's and PM's), indinavir, metoprolol, imipramine, and lithium. The x-axis represents change relative to the reference value.*

FDA Label Image

Image (Eb320e98 85d0 421f 963d 825fb8e3c621 04)

A forest plot chart displaying fold change and 90% confidence intervals for pharmacokinetic parameters (Cmax and AUC) of various analytes interacting with drugs such as ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, haloperidol, caffeine, tolbutamide, and lithium. The x-axis represents change relative to the reference value from 0 to 3, with points and error bars indicating variability for each analyte and pharmacokinetic measure.*

FDA Label Image

Sl-37.5mg-90c (Eb320e98 85d0 421f 963d 825fb8e3c621 05)

Label for Venlafaxine Hydrochloride Extended-Release Capsules, USP 37.5 mg, from Zydus Pharmaceuticals USA Inc. The label includes dosage strength, quantity (90 capsules), storage instructions, child-resistant packaging note, and pharmacist dispensing instructions with a medication guide. It features the NDC 70710-1698-9 and emphasizes keeping drugs out of reach of children.*

FDA Label Image

Sl-75 mg -90c (Eb320e98 85d0 421f 963d 825fb8e3c621 06)

Label for Venlafaxine Hydrochloride Extended-Release Capsules, USP 75 mg by Zydus Pharmaceuticals USA Inc. The label states the package contains 90 capsules, is for prescription use only, and includes storage instructions, child-resistant packaging notice, and distributor information.*

FDA Label Image

Sl-150mg-90c (Eb320e98 85d0 421f 963d 825fb8e3c621 07)

Label for Venlafaxine Hydrochloride Extended-Release Capsules, USP 150 mg by Zydus Pharmaceuticals USA Inc. The package contains 90 capsules. The label includes storage instructions, child-resistance notice, and dispensing warnings. The product is Rx only and manufactured by Zydus Lifesciences Ltd., Ahmedabad, India, with distribution by Zydus Pharmaceuticals (USA) Inc., Pennington, NJ.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.